Aurobindo Pharma Limited (AUROPHARMA) — Capital Reinvestment Ratio
Latest as of September 2025:
0.47x
Aurobindo Pharma Limited (AUROPHARMA) has a Capital Reinvestment Ratio of 0.47x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs28.85 Billion) in capital expenditures (Rs13.63 Billion). See AUROPHARMA FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.47x
Capex / Operating Cash Flow
Operating Cash Flow
Rs28.85 Billion
INR
Capital Expenditures
Rs13.63 Billion
INR
Data as of
Sep 2025
Most recent filing
Aurobindo Pharma Limited Capital Reinvestment Ratio (2004–2026)
This chart tracks Aurobindo Pharma Limited's Capital Reinvestment Ratio across 22 annual periods.
Annual Capital Reinvestment Ratio for Aurobindo Pharma Limited (2004–2026)
Year-by-year Capital Reinvestment Ratio for Aurobindo Pharma Limited from 2004 to 2026. For live market cap and broader valuation context, see Aurobindo Pharma Limited stock valuation.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.49x | Rs55.13 Billion | Rs26.86 Billion | ▼ -2.8% |
| 2025 | 0.50x | Rs39.25 Billion | Rs19.68 Billion | ▼ -65.7% |
| 2024 | 1.46x | Rs24.35 Billion | Rs35.62 Billion | ▲ +28.3% |
| 2023 | 1.14x | Rs23.87 Billion | Rs27.20 Billion | ▲ +111.4% |
| 2022 | 0.54x | Rs50.16 Billion | Rs27.05 Billion | ▼ -4.2% |
| 2021 | 0.56x | Rs33.29 Billion | Rs18.74 Billion | ▲ +72.3% |
| 2020 | 0.33x | Rs43.81 Billion | Rs14.31 Billion | ▼ -65.4% |
| 2019 | 0.94x | Rs16.51 Billion | Rs15.59 Billion | ▲ +20.6% |
| 2018 | 0.78x | Rs19.55 Billion | Rs15.30 Billion | ▲ +51.5% |
| 2017 | 0.52x | Rs32.79 Billion | Rs16.94 Billion | ▼ -53.1% |
| 2016 | 1.10x | Rs14.20 Billion | Rs15.66 Billion | ▲ +77.5% |
| 2015 | 0.62x | Rs12.37 Billion | Rs7.68 Billion | ▲ +2.8% |
| 2014 | 0.60x | Rs6.46 Billion | Rs3.90 Billion | ▼ -39.2% |
| 2013 | 0.99x | Rs2.75 Billion | Rs2.73 Billion | ▼ -43.2% |
| 2012 | 1.75x | Rs3.26 Billion | Rs5.71 Billion | ▼ -18.0% |
| 2011 | 2.14x | Rs3.35 Billion | Rs7.16 Billion | ▲ +118.1% |
| 2010 | 0.98x | Rs4.29 Billion | Rs4.20 Billion | ▼ -72.4% |
| 2009 | 3.55x | Rs1.36 Billion | Rs4.83 Billion | ▲ +128.8% |
| 2008 | 1.55x | Rs1.59 Billion | Rs2.46 Billion | ▼ -91.3% |
| 2007 | 17.79x | Rs186.50 Million | Rs3.32 Billion | ▲ +560.9% |
| 2005 | 2.69x | Rs1.22 Billion | Rs3.29 Billion | ▼ -73.3% |
| 2004 | 10.08x | Rs198.90 Million | Rs2.00 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow